Venture_Socks_RZ_RGB_300dpi(2)_edited.pn

WINNERS

Polyneuron Pharmaceuticals

2014

Health & Nutrition

Polyneuron develops a new drug class for the treatment of autoimmune diseases affecting the nervous system. Their Antibody-Catch™ platform technology enables the rational design of immunomodulatory compounds that selectively eliminate disease-causing autoantibodies. The platform carries the potential to realize breakthrough therapies for specific autoimmune conditions.

Venture_GreenLayer_v2_edited.png